MAISON POMMERY & ASSOCIES (POMRY) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of MAISON POMMERY & ASSOCIES €1.75, price €9.00, upside -80.6%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value €1.75 · Strongly overvalued (−81%)
!Quality 42/100
!Weak Growth(revenue 3y +0.3 %/yr)
!Thin margins · 0.5% net margin (TTM)
!Moderate debt · negative free cash flow
!Trails peers(4/11)
!Narrow moat32/100
!Evidence only low, so the estimate is less certain
Watch MAISON POMMERY & ASSOCIES for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Maison Pommery & Associés, together with its subsidiaries, produces and sells wines and champagnes in France, Europe, and internationally. It operates through Champagne and Other Items, and Sable and Provence Wines segments.
Show more
Maison Pommery & Associés, together with its subsidiaries, produces and sells wines and champagnes in France, Europe, and internationally. It operates through Champagne and Other Items, and Sable and Provence Wines segments. The company was formerly known as Vranken-Pommery Monopole Société Anonyme and changed its name to Maison Pommery & Associés in January 2026. Maison Pommery & Associés was founded in 1976 and is headquartered in Reims, France. Maison Pommery & Associés operates as a subsidiary of Compagnie Vranken.
Stock analysis
MAISON POMMERY & ASSOCIES (POMRY) currently trades at €9.00, while our model-based Fair Value estimate is €1.75, implying the stock looks roughly 414.4% overvalued today.
Show more
Valuation
Bull case: the Dividend Discount group reads highest at a median of €5.95 per share, and 4 of the 11 models we run sit above the €9.00 price.
Bear case: the Earnings-Based group reads lowest at €0.8600, and 7 of the 11 models stay below the price. Evidence for this calculation is low.
Scenario range: €1.31 (bear) to €2.83 (bull), the price of €9.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
MAISON POMMERY & ASSOCIES reported revenue of €304M in FY2024 versus €301M in FY2021, a compound +0.3%/yr. Reported net income was €915K in FY2024, compounding −50.4%/yr from FY2021.
Key figures
Market cap €93.3M · P/E ratio 2.5 · EPS (TTM) €3.60 · Dividend yield 7.6% · Net margin 0.3% · Return on equity 0.3% · Return on assets (EBIT) 2.7% · Operating margin 12.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
For context, the median of 10 Consumer Defensive peers we cover trades at 32% fair-value upside, at −81%, POMRY screens richer than that median.
Fair Value models
Bear €1.31Fair Value €1.75Bull €2.83
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (€3.60 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.12/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−10.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.3%
’21
’22
’23
’24
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+10.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.7%
Dividend (yield on the price)7.6%
Profit margin 2021 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 12%
Compare MAISON POMMERY & ASSOCIES with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Beverages - Wineries & Distilleries · 98 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is MAISON POMMERY & ASSOCIES (POMRY) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €1.75 versus a price of €9.00, about −81% upside (overvalued).
What is the fair value of POMRY?
Our model-based fair value for MAISON POMMERY & ASSOCIES is €1.75 (as of Sep 23, 2026), built from audited fundamentals. The current price: €9.00.
What is the quality score of POMRY?
MAISON POMMERY & ASSOCIES has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MAISON POMMERY & ASSOCIES (POMRY)?
Our model-based price target is the fair value of €1.75 (as of Sep 23, 2026) from 12 valuation models. Cautious scenario €1.31, optimistic scenario €2.83. It is a calculation from audited fundamentals, not an analyst target.
What is the MAISON POMMERY & ASSOCIES stock forecast for 2026?
Our models put fair value at €1.75, about −81% upside versus a price of €9.00 (overvalued). Cautious scenario €1.31, optimistic scenario €2.83. The calculation is refreshed regularly with new filings.
What is the revenue of MAISON POMMERY & ASSOCIES (POMRY)?
MAISON POMMERY & ASSOCIES reported trailing-twelve-month revenue of about €304M (latest available figure, as of Sep 23, 2026).
Does MAISON POMMERY & ASSOCIES pay a dividend?
MAISON POMMERY & ASSOCIES currently shows a dividend yield of about 7.62% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of MAISON POMMERY & ASSOCIES (POMRY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MAISON POMMERY & ASSOCIES it is €1.75 per share (as of Sep 23, 2026), against a price of €9.00. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is MAISON POMMERY & ASSOCIES stock overvalued or undervalued in 2026?
As of Sep 23, 2026, POMRY trades above its calculated fair value: price €9.00, fair value €1.75, a gap of about −81% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of POMRY?
No. The price is what the market pays today (€9.00); the fair value is what the company's own numbers justify (€1.75). For MAISON POMMERY & ASSOCIES the two are €7.25 per share apart. That gap is exactly why we show both numbers side by side.
How much is MAISON POMMERY & ASSOCIES worth?
The market values MAISON POMMERY & ASSOCIES at about €93.3M (market capitalisation, as of Sep 23, 2026). Per share that is €9.00; our models calculate a fair value of €1.75 per share.
What do the bullish and bearish scenarios say about POMRY?
Our models span a range for MAISON POMMERY & ASSOCIES: cautious scenario €1.31, base €1.75, optimistic €2.83 per share (as of Sep 23, 2026, price €9.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of POMRY?
MAISON POMMERY & ASSOCIES trades at a price-to-earnings ratio of 2.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €1.75 is built from several models across several years. Other multiples: PEG 2.6.
What is the PEG ratio of POMRY?
The PEG ratio of MAISON POMMERY & ASSOCIES is 2.64 (P/E divided by earnings growth, as of Sep 23, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of MAISON POMMERY & ASSOCIES (POMRY)?
Balance-sheet figures for MAISON POMMERY & ASSOCIES (as of Sep 23, 2026): return on equity 0.3%, debt of 1.16 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
Which stocks are comparable to MAISON POMMERY & ASSOCIES?
From the same area (Consumer Defensive) we also value Kweichow Moutai Co, Wuliangye Yibin Co, Shanxi Xinghuacun Fen Wine Factory Co, Luzhou Laojiao Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MAISON POMMERY & ASSOCIES stock attractive at the current price?
The data as of Sep 23, 2026: price €9.00, calculated fair value €1.75 (−81%), Quality Score 42/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of POMRY calculated?
We run MAISON POMMERY & ASSOCIES through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €1.75, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. MAISON POMMERY & ASSOCIES itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MAISON POMMERY & ASSOCIES (POMRY)?
The closing price on Sep 24, 2026 was €9.00. Our model-based fair value is €1.75, about −81% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MAISON POMMERY & ASSOCIES right now?
The price sits above even our optimistic bull case (€2.83). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (€1.31 to €2.83) leaves room in how you read the outcome.
Key figures of MAISON POMMERY & ASSOCIES
How large is the market capitalisation of MAISON POMMERY & ASSOCIES (POMRY)?
The market capitalisation of MAISON POMMERY & ASSOCIES is €93.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of MAISON POMMERY & ASSOCIES (POMRY)?
Earnings per share at MAISON POMMERY & ASSOCIES are €3.60 (price ÷ EPS = P/E 2.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MAISON POMMERY & ASSOCIES (POMRY)?
The dividend yield of MAISON POMMERY & ASSOCIES is 7.6% (payout 19.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MAISON POMMERY & ASSOCIES (POMRY)?
The net margin of MAISON POMMERY & ASSOCIES is 0.3% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MAISON POMMERY & ASSOCIES (POMRY)?
The return on equity (ROE) of MAISON POMMERY & ASSOCIES is 0.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MAISON POMMERY & ASSOCIES (POMRY)?
On an EBIT basis the return on assets of MAISON POMMERY & ASSOCIES is 2.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MAISON POMMERY & ASSOCIES (POMRY)?
The operating margin of MAISON POMMERY & ASSOCIES is 12.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MAISON POMMERY & ASSOCIES (POMRY)?
Revenue at MAISON POMMERY & ASSOCIES is growing −0.2% versus a year earlier (3y avg +0.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does MAISON POMMERY & ASSOCIES (POMRY) generate?
The free cash flow of MAISON POMMERY & ASSOCIES is −€2.4M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does MAISON POMMERY & ASSOCIES (POMRY) carry?
The net debt of MAISON POMMERY & ASSOCIES is €704M (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch MAISON POMMERY & ASSOCIES in the live analysis
One click puts MAISON POMMERY & ASSOCIES on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
